Degarelix: A Novel Gonadotropin-Releasing Hormone (GnRH) Receptor Blocker—Results from a 1-yr, Multicentre, Randomised, Phase 2 Dosage-Finding Study in the Treatment of Prostate Cancer - Concepedia

Concepedia

Publication | Closed Access

Degarelix: A Novel Gonadotropin-Releasing Hormone (GnRH) Receptor Blocker—Results from a 1-yr, Multicentre, Randomised, Phase 2 Dosage-Finding Study in the Treatment of Prostate Cancer

126

Citations

17

References

2008

Year

Hendrik Van Poppel, Bertrand Tombal, Jean J. de la Rosette, Bo‐Eric Persson, Jens-Kristian Jensen, Tine Kold Olesen

European Urology

UrologyNovel Gonadotropin-releasing HormoneMedicineHormonal ReceptorPharmacotherapyProstatic DiseasePhase 2EndocrinologyPharmacologyEndocrine-related CancerDrug Discovery

References

	Year	Citations

Page 1